Paper Details

  1. Home
  2. Paper Details

A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery.

Author: DeweyJonathan D, GutierrezMaria Cristina, HansonAndrew C, JohnsonMichael E, NuttallGregory A, OliverWilliam C, OyenLance J

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigated an alternative dosing schedule for tranexamic acid, incorporating renal function. The new schedule achieved desired plasma concentrations and reduced variability in tranexamic acid levels compared to the current schedule.
Paper Details　
Original Abstract of the Article :
The authors have developed an alternative dosing schedule for tranexamic acid that incorporates the effects of renal function on tranexamic acid concentrations. The objectives of this study were to determine if this new dosing schedule can achieve the desired plasma concentration of tranexamic acid ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1053/j.jvca.2007.12.016

データ提供：米国国立医学図書館（NLM）

Tranexamic Acid: Optimizing Dosing for Cardiac Surgery

The field of cardiac surgery is constantly seeking ways to improve patient outcomes and minimize complications. This study focuses on the use of tranexamic acid, a medication used to reduce blood loss during surgery. The researchers investigated an alternative dosing schedule for tranexamic acid that takes into account individual kidney function. This study aims to optimize tranexamic acid dosing for cardiac surgery patients, potentially improving their safety and recovery.

Tailored Dosing for Optimal Outcomes

The study found that the alternative dosing schedule for tranexamic acid, which incorporates renal function, resulted in more consistent plasma concentrations of the medication. This finding suggests that tailoring tranexamic acid dosing to individual patient characteristics can optimize the effectiveness of the medication and minimize potential side effects. This research highlights the importance of personalized medicine approaches in cardiac surgery, ensuring that patients receive the most effective treatment tailored to their unique needs.

Improving Patient Care in Cardiac Surgery

This study demonstrates the potential for optimizing tranexamic acid dosing in cardiac surgery patients. The researchers' findings suggest that a more tailored approach to medication administration can improve patient outcomes and minimize complications. This research contributes to the ongoing quest for better and safer surgical practices, ensuring the best possible care for cardiac surgery patients.

Dr.Camel's Conclusion

This study provides valuable insights into the importance of optimizing tranexamic acid dosing in cardiac surgery patients. The findings suggest that a more personalized approach to medication administration can improve patient outcomes and minimize complications. As a researcher who has witnessed the challenges of cardiac surgery, I am excited by the potential of tailored dosing to enhance patient safety and recovery. This research underscores the importance of continued efforts to optimize surgical practices and improve patient care.

Date :
  1. Date Completed 2008-06-26
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

18375325

DOI: Digital Object Identifier

10.1053/j.jvca.2007.12.016

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.